期刊
PHYSIOLOGICAL GENOMICS
卷 53, 期 2, 页码 51-60出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiolgenomics.00087.2020
关键词
ACE2; complex disease; COVID-19; RAAS; SARS-CoV-2
资金
- NIH [P40OD021331, R01CA219144-05S1]
- deArce-Koch Memorial Endowment funds
- NSF NOA-AGEP [1432878]
- Fulbright Foreign Student Program [E0610013, IIE: PS00280384]
The novel coronavirus disease COVID-19 has posed a global challenge by infecting human cells via binding with ACE2, resulting in respiratory illnesses like bronchitis and pneumonia.
A novel coronavirus disease, COVID-19, has created a global pandemic in 2020, posing an enormous challenge to healthcare systems and affected communities. COVID-19 is caused by severe acute respiratory syndrome (SARS)-coronavirus-2 (CoV-2) that manifests as bronchitis, pneumonia, or a severe respiratory illness. SARS-CoV-2 infects human cells via binding a spike protein on its surface to angiotensin-converting enzyme 2 (ACE2) within the host. ACE2 is crucial for maintaining tissue homeostasis and negatively regulates the renin-angiotensin-aldosterone system (RAAS) in humans. The RAAS is paramount for normal function in multiple organ systems including the lungs, heart, kidney, and vasculature. Given that SARS-CoV-2 internalizes via ACE2, the resultant disruption in ACE2 expression can lead to altered tissue function and exacerbate chronic diseases. The widespread distribution and expression of ACE2 across multiple organs is critical to our understanding of the varied clinical outcomes of COVID-19. This perspective review based on the current literature was prompted to show how disruption of ACE2 by SARS-CoV2 can affect different organ systems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据